Klinique Med (Thailand) Performance
| KLINIQ Stock | 26.50 0.25 0.95% |
The company secures a Beta (Market Risk) of -0.18, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Klinique Med are expected to decrease at a much lower rate. During the bear market, Klinique Med is likely to outperform the market. At this point, Klinique Med has a negative expected return of -0.28%. Please make sure to verify Klinique Med's potential upside, and the relationship between the jensen alpha and daily balance of power , to decide if Klinique Med performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days The Klinique Med has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Dividend Yield | 0.0112 |
Klinique |
Klinique Med Relative Risk vs. Return Landscape
If you would invest 3,200 in The Klinique Med on November 3, 2024 and sell it today you would lose (550.00) from holding The Klinique Med or give up 17.19% of portfolio value over 90 days. The Klinique Med is generating negative expected returns and assumes 2.2948% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than Klinique, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Klinique Med Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Klinique Med's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as The Klinique Med, and traders can use it to determine the average amount a Klinique Med's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1231
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KLINIQ |
Estimated Market Risk
| 2.29 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Klinique Med is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Klinique Med by adding Klinique Med to a well-diversified portfolio.
Klinique Med Fundamentals Growth
Klinique Stock prices reflect investors' perceptions of the future prospects and financial health of Klinique Med, and Klinique Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Klinique Stock performance.
| Return On Equity | 0.95 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 9.44 B | |||
| Shares Outstanding | 220 M | |||
| Price To Book | 39.18 X | |||
| Price To Sales | 5.73 X | |||
| Revenue | 1.49 B | |||
| EBITDA | 288.81 M | |||
| Book Value Per Share | 0.95 X | |||
| Earnings Per Share | 1.09 X | |||
About Klinique Med Performance
By analyzing Klinique Med's fundamental ratios, stakeholders can gain valuable insights into Klinique Med's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Klinique Med has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Klinique Med has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Klinique Med performance evaluation
Checking the ongoing alerts about Klinique Med for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Klinique Med help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Klinique Med generated a negative expected return over the last 90 days | |
| About 74.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Klinique Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Klinique Med's stock is overvalued or undervalued compared to its peers.
- Examining Klinique Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Klinique Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Klinique Med's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Klinique Med's stock. These opinions can provide insight into Klinique Med's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Klinique Stock analysis
When running Klinique Med's price analysis, check to measure Klinique Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klinique Med is operating at the current time. Most of Klinique Med's value examination focuses on studying past and present price action to predict the probability of Klinique Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klinique Med's price. Additionally, you may evaluate how the addition of Klinique Med to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |